Page last updated: 2024-10-26

dipyridamole and Shock

dipyridamole has been researched along with Shock in 4 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research Excerpts

ExcerptRelevanceReference
"To report a case of fulminant shock and noncardiogenic pulmonary edema induced by intravenously administered dipyridamole."7.77Dipyridamole-associated shock and pulmonary edema. ( Arias, SA; Dioverti, M; Fishman, R; Lall, P; Manthous, C; Moskowitz, R; Nair, S; Schussheim, AE; Zarich, S, 2011)
"This is the first case report of a circulatory collapse induced by an oral intake of dipyridamole."5.48Oral Dipyridamole-Associated Circulatory Collapse. ( Jolma, P; Ollikainen, J; Uurto, I, 2018)
" The reported highest dosage of acute ingestion was 1250 mg."5.29Profound shock resulting from a large dose of dipyridamole. ( Chen, JH; Chen, ZC; Kwan, CM, 1994)
"To report a case of fulminant shock and noncardiogenic pulmonary edema induced by intravenously administered dipyridamole."3.77Dipyridamole-associated shock and pulmonary edema. ( Arias, SA; Dioverti, M; Fishman, R; Lall, P; Manthous, C; Moskowitz, R; Nair, S; Schussheim, AE; Zarich, S, 2011)
"This is the first case report of a circulatory collapse induced by an oral intake of dipyridamole."1.48Oral Dipyridamole-Associated Circulatory Collapse. ( Jolma, P; Ollikainen, J; Uurto, I, 2018)
" The reported highest dosage of acute ingestion was 1250 mg."1.29Profound shock resulting from a large dose of dipyridamole. ( Chen, JH; Chen, ZC; Kwan, CM, 1994)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jolma, P1
Ollikainen, J1
Uurto, I1
Dioverti, M1
Fishman, R1
Moskowitz, R1
Arias, SA1
Nair, S1
Lall, P1
Schussheim, AE1
Zarich, S1
Manthous, C1
Chen, ZC1
Kwan, CM1
Chen, JH1
Vincent, JL1
Brimioulle, S1
Berre, J1
Kahn, RJ1

Trials

1 trial available for dipyridamole and Shock

ArticleYear
Prevention of the adult respiratory distress syndrome with dipyridamole.
    Critical care medicine, 1985, Volume: 13, Issue:10

    Topics: Adult; Aged; Dipyridamole; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; P

1985

Other Studies

3 other studies available for dipyridamole and Shock

ArticleYear
Oral Dipyridamole-Associated Circulatory Collapse.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:12

    Topics: Administration, Oral; Aged; Delayed-Action Preparations; Dipyridamole; Humans; Ischemic Attack, Tran

2018
Dipyridamole-associated shock and pulmonary edema.
    The Annals of pharmacotherapy, 2011, Volume: 45, Issue:7-8

    Topics: Aged; Dipyridamole; Female; Humans; Infusions, Intravenous; Myocardial Perfusion Imaging; Pulmonary

2011
Profound shock resulting from a large dose of dipyridamole.
    International journal of cardiology, 1994, Volume: 46, Issue:1

    Topics: Adult; Aminophylline; Coma; Dipyridamole; Dopamine; Electrocardiography; Female; Humans; Poisoning;

1994